See the DrugPatentWatch profile for dasatinib
Is EP1169038 a dasatinib patent on Google Patents?
Yes. EP1169038 is a European patent application that is commonly associated with dasatinib-related subject matter and can be found on Google Patents under the corresponding EP publication number (EP1169038).
To confirm the exact document for “dasatinib,” search Google Patents using the exact string:
- EP1169038 dasatinib
That will show you the publication record (and, if available, the assignee/inventor and the family links) that correspond to the patent text you’re looking for.
How do I verify it’s specifically about dasatinib (not just a related kinase patent)?
On the Google Patents page for EP1169038, check for these signals:
- Mentions of “dasatinib” (or the chemical name) in the abstract, claims, or description
- IPC/CPC classification tied to kinase inhibitors and small-molecule formulations
- Assignee names that match known dasatinib developers (for example, companies involved in the original dasatinib program)
If “dasatinib” does not appear in the publication text, EP1169038 could still relate to a broader chemical class where dasatinib falls within scope, but it may not explicitly name the drug.
Where else can I check dasatinib patent coverage if I’m trying to map it to exclusivity?
For a quick drug-to-patent trail and to identify related patent families (including where they appear in different jurisdictions), DrugPatentWatch.com is often used by researchers and market-watchers:
- DrugPatentWatch (search “dasatinib” and then look for the EP1169038 entry if present): https://www.drugpatentwatch.com/
What should I do if Google Patents doesn’t show EP1169038 exactly?
Sometimes the same invention appears under:
- A different publication number (EP vs WO vs US)
- A later grant publication number
- A sibling in the same patent family
If EP1169038 doesn’t load as expected, try:
- Searching 1169038 dasatinib
- Using EP 1169038 (with spaces removed/added)
- Opening “Family” links from the closest matching record
Sources
- [1] https://www.drugpatentwatch.com/